Link: https://links.sgx.com/1.0.0/corporate-announcements/KBZ6ZG99SZIL4GKW/664092f51af674ca1ebed0bf272e857d2ca153acc46446557bb36a5d9a02410c

Summary:

• Q3 revenue and EBITDA both rose 16% year-on-year to RM6.6 billion and RM1.5 billion, respectively; PATMI up 15% to RM616 million.

• Malaysia operations strengthened with a pivot toward daycare services and increased medical tourism share, particularly from Island Hospital.

• Fortis and Gleneagles India deepened operational partnership, achieving clinical synergies and greater efficiencies; India segment benefited from formal operations and maintenance service agreement.

• Singapore’s Mount Elizabeth Orchard fully reopened, contributing to stable EBITDA despite payor and cost inflation headwinds.

• Group occupancy reached 68%; inpatient admissions and lab tests up 5–6%.

• Balance sheet remains sound with RM4.4 billion operating cash flow and RM1.4 billion overall cash balance.

• The group is progressing on a multi-year transformation plan focused on clinical excellence, new care models, operational efficiency, and technological innovation.

• Outlook: IHH to maintain robust profit margins, manage inflationary pressures, benefit from Singapore’s NEHR participation, and leverage new growth flexibility in India post-Fortis acquisition.